WPI 845 (Glipizide extended release 10 mg)

Pill imprint WPI 845 has been identified as Glipizide extended release 10 mg.

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 10 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for WPI 845 (Glipizide extended release 10 mg)

Glipizide extended release 10 mg WPI 845
Glipizide extended release 10 mg WPI 845
Glipizide extended release 10 mg WPI 845
Glipizide extended release
WPI 845
10 mg
6.00 mm
Prescription only
Drug Class:
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Watson Laboratories, Inc.
National Drug Code (NDC):
Inactive Ingredients:
acetyltributyl citrate
hydroxyethyl cellulose (2000 mpa.s at 1%)
hydroxypropyl cellulose (type h)
lactose monohydrate
magnesium stearate
methacrylic acid - methyl methacrylate copolymer (1:1)
polyethylene glycol
isopropyl alcohol
ferrosoferric oxide
butyl alcohol
propylene glycol
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0112 Amerisource Health Services
00228-2900 Actavis
54569-5548 A S Medication Solutions LLC (repackager)
54868-4988 Physicians Total Care Inc (repackager)
58016-0691 Southwood Pharmaceuticals Inc (repackager)
55887-0179 Diversified Healthcare Services Inc (repackager)
55289-0301 PDRX Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)